DiaMedica Therapeutics Inc

DMAC

Add to Watchlist

6.735USD

-0.085-1.25%

Close 07-24 16:00（ET）Quotes delayed by 15 min

362.90MMarket Cap

LossP/E TTM

DiaMedica Therapeutics Inc

6.735

-0.085-1.25%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

DiaMedica Therapeutics Inc's Company Valuation

Currency: USD Updated: 2026-07-24

Previous score

7.24

Change

The current valuation score of DiaMedica Therapeutics Inc is 7.24, ranking 255 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -9.56, which is -73.31% below the recent high of -2.55 and -36.89% above the recent low of -13.09.

P/E

Relevant data have not been disclosed by the company yet.

P/B

Relevant data have not been disclosed by the company yet.

P/CF

Relevant data have not been disclosed by the company yet.